Search results
People also ask
Who is Supriya LifeScience Limited?
How to contact Supriya LifeScience?
Who is Supriya LifeScience L mited?
How strong was Supriya LifeScience in 2022-23?
Ms. Shivani Wagh is the Joint Managing Director of Supriya Lifescience Limited. She joined the organization in 2014 after completing her education. Miss. Wagh has completed her graduation in Bachelor of Management studies from Mumbai University.
- Building for the future - Supriya Lifescience
14 Chairman and Managing Director’s Overview 16 Our...
- Building for the future - Supriya Lifescience
Aug 5, 2024 · Dr. Satish Wagh, founder of Supriya Lifescience Ltd., has been appointed as the executive chairman. His vast experience and visionary leadership have been instrumental in establishing Supriya Lifescience as a prominent name in the pharmaceutical industry.
Aug 2, 2024 · Dr Satish Wagh, Founder, Supriya Lifescience Ltd, has been appointed as the Executive Chairman. His vast experience and visionary leadership have been instrumental in establishing Supriya Lifescience as a prominent name in the pharmaceutical industry.
14 Chairman and Managing Director’s Overview 16 Our strategic overview 18 Our areas of presence 20 Our value-accretive business model 30 Our business drivers 40 Our employee testimonials 42 Supriya’s EHS priority 46 Profile of Board of Directors 50 Management discussion and analysis 56 Risk management at Supriya Lifescience Statutory section
2 days ago · Get Supriya Lifescience Ltd. share price today, stock analysis, stock rating, price valuation, performance, fundamentals, market cap, shareholding, and financial report.
- ₹627.40 - ₹670
- Supriya Lifescience Ltd.
- The total asset value of Supriya Lifescience Ltd. stood at ₹ 843 Cr as on 30-Sep-23
- The share price of Supriya Lifescience Ltd. is ₹322.00 (NSE) and ₹322.60 (BSE) as of 04-Jan-2024 IST. Supriya Lifescience Ltd. has given a return o...
- Supriya Lifescience Ltd. has a market capitalisation of ₹ 2,593 Cr as on 04-Jan-2024. As per Value Research classification, it is a Small Cap company.
- The P/B ratio of Supriya Lifescience Ltd. is 3.44 times as on 04-Jan-2024, a 0.05% premium to its peers’ median range of 3.28 times.
- The P/E ratio of Supriya Lifescience Ltd. is 25.89 times as on 04-Jan-2024, a -0.14% premium to its peers’ median range of 30.01 times.
- Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC Step...
- Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide. It...
- The promoter of Supriya Lifescience Ltd. is Satish Waman Wagh. Satish Waman Wagh owns 67.64 per cent of the total equity. The chairman of the compa...
- The promoters of Supriya Lifescience Ltd. have pledged 0% of the total equity as on Sep-23.
As Chairman of CETP (Lote Parshuram Environment Protection Co-operative Society Limited), Dr. Wagh was responsible for generating Rs. 46 Cr. for Upgradation of Common Effluent Treatment Plants for Lote and Roha Industrial Areas in Maharashtra from Ministry of Commerce & Industry.
Dr. Prashant Baban Zate. Head of Corporate Quality Assurance and Regulatory Affairs. Company profile for Supriya Lifescience Limited (NSE: SUPRIYA) with a description, list of executives, contact details and other key facts.
